Annals ofRheumatoid Arthritis

Volume: 4 - Number: 41 - December 15, 2006

Outstanding

Will our current success in treating rheumatoid arthritis hinder new drug development? That is the question!!

Is progressive osteoarthritis an atheromatous vascular disease?

Antiphospholipid antibody tests: spreading the net

Very early spondyloarthritis: where the inflammation in the sacroiliac joints starts

Concise reports

RS3PE syndrome presenting as vascular endothelial growth factor associated disorder

Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis

Very early spondyloarthritis: where the inflammation in the sacroiliac joints starts

Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement

Editorial

Will our current success in treating rheumatoid arthritis hinder new drug development? That is the question!!

Extended reports

Activity limitations and participation restrictions in women with hand osteoarthritis: patients’ descriptions and associations between dimensions of functioning

Antiphospholipid antibody tests: spreading the net

Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

Differential effect of IL10 and TNF genotypes on determining susceptibility to discoid and systemic lupus erythematosus

Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis

ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis

Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study

Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment

Occurrence and risk factors for falls in rheumatoid arthritis

Oestrogen receptor gene polymorphisms in systemic lupus erythematosus

Oncostatin M in combination with tumour necrosis factor induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or-2

Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study

Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice

Hiphotesis

Is progressive osteoarthritis an atheromatous vascular disease?

Review

Dendritic cells, Fc receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis